Delayed inflammation decrease is associated with mortality in Tocilizumab-treated critically ill SARS-CoV-2 patients: A retrospective matched-cohort analysis.
Urbina T, Lavillegrand JR, Garnier M, Mekinian A, Pacanowski J, Mario N, Dumas G, Hariri G, Pilon A, Darrivère L, Fartoukh M, Guidet B, Maury E, Leblanc J, Chantran Y, Fain O, Lacombe K, Voiriot G, Ait-Oufella H.
Urbina T, et al. Among authors: guidet b.
Innate Immun. 2022 Jan;28(1):3-10. doi: 10.1177/17534259211064602. Epub 2022 Jan 28.
Innate Immun. 2022.
PMID: 35089113
Free PMC article.